Overview
The fund is managed with an indexed method and is distinguished by broad diversification, low tracking errors, and low-cost management.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
The MSCI Europe ex EMU Index captures large and mid cap representation in European Developed Markets countries (excluding those in the EMU and Switzerland).
The index covers approximately 85% of the free floatadjusted market capitalization in the European ex EMU ex Switzerland equity universe.
The fund is passively managed.
Benefits
Easy access to a broadly diversified portfolio of European Equities.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
Equity Europe |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
May 22, 2012
|
| Currency of account |
CHF
|
| Close of financial year |
February 28
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.16% p.a.
|
| Flat fee |
0.15% p.a.
|
| Management fee |
0.15% p.a.
|
| Total expense ratio (TER) |
0.16% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe ex EMU ex Switzerland (NR) in CHF
|
| Cut-Off Time |
14:00h(CET)
|
| Securities no. |
18572391
|
| ISIN |
CH0185723910
|
| Bloomberg Ticker |
CSIFEEF SW
|
| Reuters Id |
18572391X.CHE
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 5.13 | 6.59 | 6.28 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 12.49 | 13.45 | 28.68 |
| 3Y | |||
| 5Y | 36.97 | 64.89 | 60.26 |
| ø p.a.5Y | 6.49 | 10.52 | 9.89 |
Current data
| Net asset value | 23.04.2026 | CHF 1,719.39 |
| High - last 12 months | 17.04.2026 | CHF 1,749.17 |
| Low - last 12 months | 24.04.2025 | CHF 1,452.98 |
| Assets of the unit class in mn | 23.04.2026 | CHF 11.36 |
| Total product assets in mn | 23.04.2026 | CHF 983.70 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 9.63% | 12.14% |
| Sharpe Ratio | 31.03.2026 | 0.60 | 0.48 |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| AstraZeneca PLC | 7.04 |
| HSBC Holdings PLC | 6.48 |
| Shell PLC | 6.31 |
| BP PLC | 2.95 |
| British American Tobacco PLC | 2.94 |
| Rolls-Royce Holdings PLC | 2.94 |
| Unilever PLC | 2.83 |
| Novo Nordisk A/S | 2.69 |
| GSK PLC | 2.60 |
| Rio Tinto PLC | 2.42 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|